Our friends at Slavens Racing built their own YZ300X using a 2016 YZ250X as its starting point. And they gave us a chance to ...
Yamaha has trademarked the YZF-R2 name in India, indicating that the brand is possibly working on a new 200cc supersport. The ...
IWATA, November 25, 2025 - Yamaha Motor Co., Ltd. (Tokyo: 7272) today announced the expansion of its Robonity* series of single-axis robots and motorless single-axis actuators with the addition of a ...
Yamaha MT-03 Price starts at Rs. 3.30 Lakh which is Rs. 1.57 Lakh costlier than base model of GoBike V6 priced at Rs. 1.72 Lakh. In technical specifications, Yamaha MT-03 is powered by 321 cc engine.
JHEV Delta V6 Price starts at Rs. 1.52 Lakh which is Rs. 2,009 costlier than base model of Yamaha XSR 155 priced at Rs. 1.50 Lakh. In technical specifications, Yamaha XSR 155 is powered by 155 cc ...
Yamaha unveiled the MOTOROiD2 concept, an electric motorcycle prototype featuring AI image recognition and AMCES self-balancing technology The design is intentionally lifelike and futuristic, with a ...
One of these players is a pharma giant trading for a dirt-cheap price today. The second stock here is a biotech company that’s recently proven the strength of its game-changing technology. These ...
Hosted on MSN
Lotus Emira V6 100-200 Acceleration & Sound
Enjoy the thrilling performance of the Lotus Emira V6 with an acceleration test from 100-200 km/h on the German Autobahn. The supercharged V6 delivers a pure driving experience, blending lightweight ...
Google today announced “AI Plus” as a new subscription tier “designed to empower people in emerging markets to do more with Google AI, for less.” This new Google AI Plus plan comes in between the free ...
Even if you only have $200 to invest, you can find amazing stocks that could reward you well over the long term. It's even better if you have $200 to spend monthly, which is an important part of a ...
Healthcare is a complex sector, but some dividend payers have proven incredibly reliable over the long term. Medtronic is a medical device powerhouse closing in on Dividend King status. Merck is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results